News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

EnVivo Pharmaceuticals, Inc. to Highlight Clinical Stage Program at Neuroscience 2011


10/31/2011 7:54:42 AM

WATERTOWN, Mass.--(BUSINESS WIRE)--EnVivo Pharmaceuticals, a company dedicated to developing a broad range of novel central nervous system (CNS) therapies, announced today that it has been selected to discuss its lead program EVP-6124, a nicotinic alpha-7 agonist, at the Society for Neuroscience 41st Annual Meeting. Neuroscience 2011 will be held Nov. 12-16, 2011 at the Walter E. Washington Convention Center in Washington D.C.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES